Ski is an oncoprotein that represses transforming growth factor-b and nuclear receptor signaling. Despite evidence that relates increased Ski protein levels directly with tumor progression in human cells, the signaling pathways that regulate Ski expression are mostly unidentified. Here we show that the Ski protein levels vary throughout the cell cycle, being lowest at G0/G1. This reduction in Ski protein levels results from proteosomal degradation as suggested by in vivo ubiquitination of Ski and the effects of proteosomal inhibitors. In contrast, an upregulation of the Ski protein was observed in cells going through mitosis. At this stage, we also found that Ski is phosphorylated. In vitro and in vivo data suggest that the phosphorylation of Ski in mitosis is carried out by the main kinase controlling the progression of mitosis, namely cdc2/cyclinB. Interestingly, immunofluorescence experiments, supported by biochemical data, show not only an increase in the Ski protein levels, but also a dramatic redistribution of Ski to the centrosomes and mitotic spindle throughout mitosis. Studies to date on Ski have focused on its role as a transcriptional regulator. However, Ski's increased level and specific relocalization during mitosis suggest that Ski might play a distinct role during this particular phase of the cell cycle.
Introduction
Ski was first identified as the transforming protein (vSki) of the avian Sloan-Kettering retrovirus that induces oncogenic transformation of chicken embryo cells Stavnezer et al., 1986) . The gene encoding the human cellular homologue of Ski (c-Ski), was subsequently cloned (Nomura et al., 1989; Stavnezer et al., 1989) and several orthologue genes have been identified. Ski acts as a transcriptional corepressor of transforming growth factor-b (TGF-b) and nuclear hormone receptors target genes (Dahl et al., 1998; Wang et al., 2000; Liu et al., 2001; Ueki and Hayman, 2003) . Overexpression of Ski induces morphological transformation in chicken and quail embryo fibroblasts and terminal muscle differentiation in quail embryo cells (Colmenares and Stavnezer, 1989; Colmenares et al., 1991) . More importantly, an increase in the expression of the Ski protein has been detected in human cell lines and tissues derived from melanoma (Fumagalli et al., 1993; Reed et al., 2001; Medrano, 2003) , colorectal cancer (Buess et al., 2004) and esophageal carcinoma (Fukuchi et al., 2004) . Of special interest, overexpression of Ski correlates directly with the progression of the malignancy and with poor clinical prognosis. Therefore, tight regulation of its levels is important to control the activity of this protein.
The Ski-related protein SnoN is rapidly degraded in response to TGF-b (Sun et al., 1999) . TGF-b-induced degradation of SnoN is dependent on the ubiquitinproteasome pathway and can be mediated by the anaphase-promoting complex and/or the Smurf2 ubiquitin ligase Stroschein et al., 2001; Wan et al., 2001) . Ski is also degraded in response to TGF-b, but to a lesser extent than SnoN (Sun et al., 1999) . Although this degradation seems to be dependent on the proteasome, not much information is available about Ski regulation by this pathway.
In the present work, we investigate the levels of Ski protein during the cell cycle. We found that Ski is ubiquitinated in vivo and the protein levels fluctuate throughout the cell cycle, being highest at mitosis. In vivo and in vitro analyses indicate that during mitosis, Ski might be a target of the cyclin-dependent kinase (cdk), cdc2. The increase in the stability of the phosphorylated form of Ski suggests that phosphorylation of Ski by cdc2 might contribute to its stabilization by protecting it from the proteasome-mediated degradation. Importantly, Ski displays a distinct pattern of localization during the progression of mitosis, being localized at the centrosomes and mitotic spindle. These results suggest that Ski might be playing a role during mitosis, in addition to its known role in transcription.
Results

Human ski is regulated in the mitotic cell cycle
To determine whether the Ski protein is regulated in a cell cycle-dependent fashion, human MG63 osteosarcoma cells stably overexpressing T7 tagged-hSki were used ( Figure 1a ). MG63 cell populations enriched in different phases of the cell cycle were obtained by serum starvation (G0), aphidicolin or nocodazole treatment (G1/S and M, respectively). FACS analysis was used to determine the DNA content of the cells (Figure 1a , upper panel). Immunoblot analysis shows the lowest level of Ski in cells that are mostly in G0 (lane 4), there is a small increase in Ski levels as the cells enter G1 (lanes 5 and 6). The highest levels of Ski were found in samples with a high percentage of mitotic cells (lanes 3 and 7) . The same blot was probed with anti-cyclin B antibody as a marker for mitotic cells and with anti-actin as a loading control. The levels of cyclin B correlate directly with the percentage of mitotic cells and with Ski levels. Actin levels were unaffected by the different conditions.
Previous antecedents show that activation of TGF-b induces Ski degradation, apparently by the proteasome (Sun et al., 1999) . Considering the cell cycle fluctuation of Ski protein levels described above, we analysed the possibility that Ski could be a substrate for ubiquitinmediated proteolysis. To address this issue, we determined whether Ski is polyubiquitinated in vivo. HEK293 cells were cotransfected with a plasmid expressing T7-tagged Ski and with a plasmid expressing His-ubiquitin. A plasmid expressing HA-c-Myc, was used as a positive control (Salghetti et al., 1999) . Ubiquitinated proteins were purified by affinity chromatography and detected by immunoblotting with antibodies directed to either the T7 or the HA epitopes (Figure 1b) . When cells were cotransfected with plasmids expressing HA-c-Myc and His-ubiquitin, several products with higher apparent masses than c-Myc were detected, these proteins are the ubiquitinated forms of c-Myc (lane 6). When cells were cotransfected with plasmids expressing T7-Ski and Hisubiquitin, it was also possible to detect ubiquitinated forms of Ski (lanes 10 and 12). Lanes 9-12 correspond to two independent transfections with plasmids expressing T7-Ski and His-ubiquitin, demonstrating the reproducible nature of the experiment. When Hisubiquitin was transfected alone, no product was detected after the purification, using either anti-HA (lane 2) or anti-T7 (data not shown) antibodies. Also no products were detected when cells were cotransfected with His-ubiquitin and an empty vector (data not shown).
To determine the stability of the Ski protein during mitosis, U2OS cells stably overexpressing T7-hSki were synchronized at prophase with nocodazole and cells were collected at different time points after release from the block (Figure 2a ). Ski levels were higher in mitotic cells than in the asynchronous cultures, and levels decreased when cells began to enter G1 and S phases. These changes in Ski expression patterns were similar to those seen for cyclin B. Interestingly, we noted that the increase in Ski level during mitosis is also accompanied by an increase in a slower mobility band form of Ski (see time zero). This form of Ski decreased first as the total levels of the protein start to decrease (compare the 0 and 1-2 h time points). A similar result was seen in MG63 cells, although there was a small difference in the time course in these cells, Figure 3a .
The cell cycle variations observed above with the exogenous-overexpressed T7-hSki protein were also evident when we examined endogenous Ski levels in Hela and U2OS cells by immunofluorescence detection ( Figure 2B , a and b). In these cell lines, the immunofluorescence signal corresponding to Ski was clearly stronger in mitotic cells, identified by 4,6-diamidino-2-phenylindole (DAPI) staining of the chromosomes. The same staining pattern was observed in MG63 and U2OS cells overexpressing T7-Ski utilized in the previous experiments (data not shown).
Ski is phosphorylated during mitosis and is an in vitro substrate of the cdk cdc2
The variation in the levels of Ski during the cell cycle and its ubiquitination encouraged us to investigate whether the inhibition of the proteasome would increase the steady-state levels of Ski in mitotic cells. MG63 cells stably overexpressing T7-Ski were blocked in prophase with nocodazole and then released from the block in the (Figure 3a , time 0 h). After the block is removed the slower migrating band decreases and there is a concomitant increase in the faster migrating band (Figure 3a, (3) (4) (5) (6) (7) (8) . The inhibition of the proteasome increased the stability of the slower migrating band such that it was still the predominant band even 8 h after the release. a-tubulin was used as a loading control (lower panel) and was unaffected by the different treatments.
As phosphorylation events are known to affect the electrophoretic mobility of proteins, we investigated whether the electrophoretic mobility shift of T7-Ski was due to cell cycle-regulated phosphorylation by treating extracts prepared from nocodazole-arrested cells with l-phosphatase prior to the analysis by Western blotting (Figure 3b ). The doublet of Ski was no longer seen in the sample treated with phosphatase, and based on the increased amount of Ski now present in the faster migrating species, it appeared that the phosphatase treatment had converted one form into the other. These data indicate that the slower migration of the T7-Ski extracted from mitotic cells resulted from phosphorylation. In the absence of phosphatase, and when the phosphatase was added in the presence of phosphatase inhibitors, the proportion of Ski present in the upper migrating band was unaffected. This indicates that it was the phosphatase activity that caused the change in migration of the protein and not a contaminating activity.
The cdc2-cyclin B kinase complex, the major cdk in mitotic cells (Nigg, 2001) , is inactivated by proteasomic degradation of the cyclin B subunit. Since this complex was active at the time when we detected the uppermigrating band of Ski, we investigated whether this kinase could be involved in the specific phosphorylation of T7-Ski. The mitosis-specific electrophoretic mobility shift was reversed in nocodazole-treated cells incubated with increasing concentrations of olomoucine, an inhibitor of cdc2 (Meijer and Raymond, 2003) (Figure 3c ), suggesting that Ski could be phosphorylated in vivo by the cdc2 kinase during mitosis, or by another kinase that is regulated by cdc2. We also found that, in vitro, cdc2 kinase can phosphorylate a GST-Ski fusion protein (Figure 3d ). Cdc2-cyclin B active complexes were incubated in the presence of [g-32 P]ATP and GSTSki fusion protein as substrate. In this assay, histone H1 and GST were used as positive and negative control substrates, respectively. Coomassie blue staining of the proteins is shown in the left panel and the autoradiography in the right one. Arrows indicate the bands corresponding to GST, histone H1 and GST-Ski. In the Coomassie blue-stained gel is possible to detect these proteins and also a predominant band of around 70 kDa that correspond to the GST-cyclin B used in the kinase reaction. Even though only a little amount of GST-Ski was present in the reaction, specific phosphorylation of GST-Ski and not GST alone was observed. These data strongly suggest that the cdc2-cyclin B kinase complex is responsible for Ski phosphorylation during mitosis.
The Ski protein is distributed to the spindle poles and localized in centrosomes during mitosis As shown above (Figure 2c ), immunofluorescence staining of a population of replicating U2OS and Hela cells revealed a stronger signal for Ski in mitotic cells, and a unique staining pattern reminiscent of the mitotic spindle was observed. To examine this localization further, we performed double-staining experiments using antibodies against Ski together with a-tubulin antibodies, which allow microtubule visualization. Confocal microscopy provided evidence for the presence of Ski protein in the mitotic spindle ( Figure 4a ). As shown in Figure 4A , a-c, there was no colocalization of Ski with a-tubulin in interphase cells. However during mitosis, Ski concentrates mostly in the mitotic spindle as shown by colocalization with a-tubulin ( Figure 4A , d-f, a metaphase is shown as an example). To corroborate and extend the above findings, the association of Ski with a-tubulin was explored by co-immunoprecipitation with anti-a-tubulin in U2OS cells overexpressing Ski (Figure 4b ). Immunoblot using anti-Ski antibody (upper) revealed the presence of Ski in the anti-a-tubulin immunoprecipitate (lane 4), whereas control mouse IgG did not precipitate Ski (lane 2). The same amount of Ski was present in the input for both control IgG and anti a-tubulin (lanes 1 and 3, respectively) . As a control, a-tubulin was detected (bottom) and it was absent in the normal IgG immunoprecipitate (lane 2).
Considering the novelty of these findings, several controls were performed to verify the specificity of the antibody (Figure 5 ). Immunofluorescence was In all, 10% inputs for both normal IgG and anti-a-tubulin are shown (lanes 1 and 3, respectively) . The precipitates were immunoblotted with mouse anti-Ski and rat anti-a-tubulin antibodies Ski in mitosis K Marcelain and MJ Hayman performed using the same anti-Ski antibody used above, but prior to staining it was preabsorbed with either GST or GST-Ski protein (Figure 5a) . Preincubation of the antibody with GST-Ski blocked the spindle staining, whereas preincubation with GST did not. In addition, the same antibody was used to stain skiÀ/À mouse embryonic fibroblasts (MEFs) and, as expected, there was no specific staining ( Figure 5b, upper panel) . However, when the same fibroblasts were transfected with the human Ski, the antibody gave a strong nuclear signal (lower panel). a-tubulin staining is shown to identify the cells.
To further analyse the distribution of Ski during mitosis, U2OS cells were immunostained with Ski and atubulin antibodies, and cells at different mitotic stages were imaged. Multicolor composite images of DAPI (blue), a-tubulin (green) and Ski (red) showed that Ski concentrates at the spindle poles throughout mitosis ( Figure 6 ). This distribution of Ski was evident in metaphase, anaphase and telophase (Figure 6a-c,  respectively) . At telophase, Ski also localized to the cleavage furrow. Subsequently, the Ski signal decreased when cells underwent cytokinesis (Figure 6d) , consistent with the decrease of Ski protein levels as the cells move into G1 (Figure 2b) .
The distribution of Ski in the mitotic spindle was stronger in metaphase and clearly concentrated mostly to the poles. To extend these observations we determined if Ski is not only localized in the mitotic spindle but also at the centrosomes (Figure 7 ). We performed nucleoplasmic extraction of U2OS cells and coimmunostained them for Ski and g-tubulin (a centrosome marker). By confocal microscopy, we found that Ski colocalizes with g-tubulin throughout mitosis ( Figure 7a) . As an example, a cell at metaphase is shown. DNA was stained with TO-PRO3. As an independent approach to confirm the association of Ski with centrosomal structures, we isolated the centrosomes of Cos-1 cells transfected with T7-Ski, according to the protocol of Blomberg-Wirschell and Doxsey (1998) . Immunoblot analysis revealed that Ski was indeed present in this centrosomal extract (Figure 7b , upper panel). The presence of centrosomes in the purified fraction was verified by labeling with a g-tubulin antibody. Antibodies against a-tubulin and actin were used as controls for the purification procedure. Both proteins were absent in the centrosomal extract (bottom panels).
The presence of Ski in the centrosomal extract in the absence of a-tubulin suggests that the localization of Ski to the centrosomes is independent of its association with the microtubules. To address this, U2OS cells were treated with nocodazole and the distributions of Ski and g-tubulin were examined by confocal microscopy (Figure 7c) . Nocodazole leads to a complete depolymerization of the cytoplasmic microtubule network. After 4 h of nocodazole treatment, Ski was still clearly associated with the centrosomes as shown by colocalization with g-tubulin. These data indicate that the centrosomal localization of Ski results from interactions with bona fide components of the centrosome.
Discussion
Ski was first identified as a protein that induces morphological transformation in chicken and quail embryo fibroblasts and terminal muscle differentiation in quail embryo cells Stavnezer et al., 1986) . Even though Ski-transforming activity in human cells has not been clearly demonstrated, mounting evidence shows an increase in the expression and protein levels of Ski in several cell lines and tissues derived from human tumors (Fumagalli et al., 1993; Reed et al., 2001; Medrano, 2003; Buess et al., 2004; Fukuchi et al., 2004) . Ski transcripts are ubiquitously expressed in virtually all adult and embryonic tissues but at relatively low and constant levels (Grimes et al., 1993; Ambrose et al., 1995) . Importantly, only small changes in the level of Ski protein are associated with malignant progression and poor clinical prognosis. Therefore, tight regulation at transcriptional and post-transcriptional levels seems to be important to control the activity of this protein.
Here, we studied post-transcriptional regulation of Ski during the cell cycle in different human cell lines. The lowest levels of Ski were found in MG63 osteoblastic-like cells induced to differentiate by serum starvation (Figure 1 ) and levels of Ski increased in highly proliferative cells, correlating directly with the levels of cyclin B. Several pieces of evidence indicate that the Ski protein levels can be regulated by proteasomemediated degradation (Sun et al., 1999) . In this pathway, proteolysis of target proteins occurs within the 26S proteasome and is preceded by substrate polyubiquitination. We found that Ski is ubiquitinated in vivo (Figure 1) , thus the decrease in the levels of Ski is most likely achieved through proteolytic destruction via the ubiquitin-proteasome pathway, as are most proteins involved in cell cycle progression (King et al., 1996) . This degradation seems to occur in G0/G1 phase, as the lowest levels of Ski were observed in those phases of the cell cycle. This result agrees with recently published data (Macdonald et al., 2004) .
In mitotic cells we found not only an increase in the Ski protein level, but also that Ski is phosphorylated (Figures 2 and 3) . Previous work indicates that Ski is phosphorylated on serine residues (Sutrave et al., 1990) , however, neither the kinases nor the putative phosphorylation sites have been identified. We found that the mitotic phosphorylation of Ski decreases when cells pass into G1. The decrease in the phosphorylated form of Ski was inhibited when cells were incubated in the presence of the proteasome inhibitor MG132 (Figure 3 ). Under these conditions, mitosis was blocked in metaphase (not shown). Therefore, the kinase involved in Ski's phosphorylation is active at this stage of the cell cycle and may also be a proteasome-regulated protein.
The decrease in the phosphorylated form of Ski when cells in mitosis were incubated with the cdk inhibitor olomoucine, the colocalization of Ski with cyclin B during mitosis (not shown), and the in vitro phosphorylation of Ski by the cdc2/cyclin B kinase indicates that the phosphorylation of Ski in mitosis may be carried out by the main kinase controlling the progression of mitosis, namely cdc2. Recently, Macdonald et al. (2004) showed a higher stability of Ski protein in Xenopus egg extracts prepared from the mitotic phase of the cell cycle. Here we show that the highest levels of Ski and the phosphorylated form of Ski were present in nocodazole-prophase arrested cells, a time when the (Nigg, 2001) , and that the Ski protein level correlated directly with the levels of cyclin B. These findings taken together suggest that the phosphorylation of Ski during mitosis might protect the protein from being degraded.
The upregulation and phosphorylation of Ski in mitosis suggests that this protein might be playing a role in this phase of the cell cycle and that its phosphorylation could be important for its function. Consistent with this assumption, immunofluorescence studies and biochemical data indicate that an important fraction of the Ski protein distributes to centrosomes and the mitotic spindle throughout mitosis (Figure 5-7) . Centrosomes are cellular organelles that regulate critical cellular activities including cell cycle progression, mitosis, cytokinesis and cell polarity (Doxsey, 2001) . In mitotic cells, centrosomes play a role in the assembly and function of mitotic spindles, and thus ensure the faithful segregation of chromosomes (Rieder et al., 2001) . The redistribution of Ski during mitosis to these structures is suggestive of a function for this protein distinct from its known role as a transcriptional corepressor.
Even though the exact function of Ski during mitosis is uncertain, the protein's structure can give us some indications. Ski is known to interact with several proteins and to be part of large protein corepressor complexes (Nagase et al., 1993; Nomura et al., 1999; Xu et al., 2000; Wu et al., 2002) . Ski has several regions which allow protein-protein interactions, including an amino terminal cysteine-rich region and a carboxy coiled-coil region. Considering these characteristics, the localization of Ski to centrosomes and mitotic spindle is compatible with a structural function for this protein in the assembly of the spindle. Identification of the binding partners of Ski in the centrosomes and spindle will be essential to validate this hypothesis.
Examples of transcription-associated factors localized to centrosomes or the mitotic spindle are certainly not abundant. One of these factors is the ID1 protein (part of the ID proteins of dominant-negative inhibitors of basic helix-loop-helix transcription factors). A recent study shows that ID1 protein localizes at the centrosomes and mitotic spindle, and ectopic expression of ID1 results in accumulation of cells with abnormal centrosome numbers (Hasskarl et al., 2004) . Like Ski, this protein acts as a negative regulator of transcription, inhibits differentiation and overexpression of ID1 has been detected in various human tumors, and in some cases is correlated with poor clinical prognosis (Maruyama et al., 1999; Benezra et al., 2001) . By analogy, Ski could play a role in the coordination of cellular processes related to centrosomes and mitotic spindle function. Therefore, a deficiency in the regulation of Ski in tumor cells could induce abnormalities in centrosomes and aneuploidy and in this way contribute to tumor progression. Further studies of tumors with increased expression levels of Ski are necessary to substantiate this theory.
Materials and methods
Plasmid constructs
pCMV-T7-hSki was generated by incorporating human-Ski cDNA into pCMV-T7. RIGB-hSki was generated by inserting T7-tagged human Ski cDNA into the retroviral expression vector RIGB (Ueki and Hayman, 2003) . We generated pGEX2T-hSki by inserting human-Ski cDNA into pGEX-KG vector. All cloning procedures were verified by DNA sequencing. The recombinant plasmids were used for GST fusion protein production. GST fusion proteins were produced in BL21 cells and recovered on glutathione-sepharose 4B beads (Amersham Biosciences).
Cell culture and transfection U2OS, MG63, Hela, HEK293, MEFs and Cos-1 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum, penicillin G (100 U/ml), and streptomycin (100 mg/ml). Expression plasmids were introduced into the cells using FuGENE 6 (Roche Applied Science). U2OS and MG63 cells stably expressing T7-Ski were obtained by retroviral transduction. Gene transfer was performed as described before (Ueki and Hayman, 2003) .
Cell cycle synchronization and analysis
Synchronization of MG63 cells was carried out as described by Yang et al. (1999) . Briefly, cells were arrested at G0 by serum starvation (0.1% serum) for 48 h and then they were collected at 24 h after refeeding with medium containing 2 mg of aphidicolin per ml (G1/S phase) or 30 h after refeeding with medium containing 0.1 mg of nocodazole per ml (M phase). U2OS cells were incubated for 16 h in medium containing 50 ng/ml of nocodazole. Where indicated, mitotic cells obtained by nocodazole treatment were incubated in the presence of olomoucine (Calbiochem) for 2-8 h at the indicated concentrations. Samples corresponding to synchronization at various stages were stained with propidium iodide and analysed by FACS (BD and Company), using a ModFit LT software (Verity Software House Inc.).
Protein extract and immunoblotting
Whole cell extract were prepared as described before . For immunoblot detection, primary antibodies used were G8 anti-v-Ski (Cascade Biotechnology), anti-T7 (Novagen), anti-b-actin (Sigma), mouse anti-a-tubulin (Sigma), anti-GFP (Sigma), anti-cyclin B1 (Santa Cruz Biotecnology) and anti-g-tubulin (Sigma).
Proteasome inhibition and in vivo ubiquitination assays
We used the proteosome inhibitor MG132 (Sigma) at a concentration of 25 mM for the time indicated in the legend of figures. Ubiquitinated intermediates in human cells were detected using the His6-tagged-ubiquitin (His-Ub) as used by Salghetti et al. (1999) . HEK293 cells were transfected with 5 mg of pCMV-T7-hSki or pCGN.Myc either in the absence or in the presence of plasmid pMT107, which encodes His-Ub. After 48 h, cells were harvested and ubiquitinated proteins were recovered by nickel-affinity chromatography.
l protein phosphatase treatment Nocodazole-treated cells were lysed in Nonidet P-40 buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40, and 10% glycerol) containing protease inhibitors. In all, 20 mg of cell extract were incubated for 30 min at 301C with 100 or 400 U of l protein phosphatase (New England Biolabs) in the presence or not of 50 mM NaF and 10 mM Na 3 VO 4 .
In vitro cdc2 kinase assay For the in vitro phosphorylation assay, 1 mg of histone H1, GST or GST-Ski proteins were incubated for 10-25 min at 301C with cdc2 kinase buffer (75 mM Tris-HCl, pH 7.5, 15 mM MgCl 2 , 1.5 mM EGTA, 3 mM dithiothreitol, 0.015% Brij 35) supplemented with 4 mCi of [g 32 -P]ATP, 100 mM unlabeled ATP, and 0.04 U of recombinant cdc2-cyclin B active complex (Upstate Biotechnology Inc.).
Indirect immunofluorescence and microscopy
Cells were grown to exponential phase on glass coverslips. They were fixed in 3.7% neutral paraformaldehyde in PBS for 10 min, permeabilized in PBS-0.2% Triton X-100 or ice-cold methanol for 10 min at room temperature. For centrosomes detection, in situ nuclear extraction was performed (De Lucia et al., 2001) . Cells were incubated for 10 min at 41C with CSK buffer (10 mM PIPES, pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl 2 , 1 mM EGTA, 0.5% Triton X-100) plus protease and phosphatase inhibitors. Then, fixed with 3% paraformaldehyde for 15 min and permeabilized with PBS-0.5% Triton X-100 for 10 min. After permeabilization, cells were blocked with 3% BSA or Image-iT Fx s signal enhancer (Molecular Probes) for 45 min. All antibodies were diluted in PBS-1% BSA. DAPI or TO-PRO 3 (Molecular Probes) were used for DNA staining. Slides were mounted with Prolong Gold antifade (Molecular Probes). Primary antibodies for these experiments included: G8 mouse mAb anti-v-Ski (1 : 200 dilution, Cascade Biotechnology), rat mAb anti-a-tubulin (1 : 300, Chemicon) and rabbit anti-g-tubulin (1 : 1000, Sigma). All secondary antibodies used were from Molecular Probes: Alexa Fluor 546 goat anti-mouse (1 : 500); Alexa Fluor 488 goat anti-rat (1 : 1000); Alexa Fluor 488 goat anti-rabbit (1 : 1000). Fluorescence microscopy was performed on an Axioskop 2 microscope (Carl Zeiss Inc.) through a Â 63/1.4 oil objective. Pictures were taken using Carl Zeiss Camera and acquired with Axiovision software. Confocal microscopy was performed in a LSM Meta 510 (Carl Zeiss Inc.), using a Â 100/ 1.4 oil objective.
Immunoprecipitation
Immunoprecipitation was performed in a buffer containing 1% Triton X-100, 10 mM Tris, pH 7.4, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 5 mM EDTA, 0.1 mM Na 3 VO 4 and protease inhibitors. In all, 10 mg of mouse anti-atubulin (Sigma) or normal mouse IgG were used to immunoprecipitate.
Isolation of centrosomes
Cos-1 cells were transfected with T7-tagged hSki 48 h prior to use. Centrosomal isolation was carried out as described by Faust et al. (2002) .
Abbreviations TGF-b, transforming growth factor-b; cdk, cyclin-dependent kinase; DAPI, 4,6-diamidino-2-phenylindole; SB, sample buffer..
